Skip to main content
Clinical Trials/PACTR201911743087495
PACTR201911743087495
Completed
Phase 4

Effectiveness of Prophylactic Intravenous Ondansetron to Reduce Pruritis after Intrathecal Fentanyl among Patients Undergoing Elective Cesarean Section in Worabe Comprehensive Specialized Hospital Southern Ethiopia, 2019.

worabe comprhensive specialized hospital0 sites102 target enrollmentOctober 8, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
worabe comprhensive specialized hospital
Enrollment
102
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
worabe comprhensive specialized hospital

Eligibility Criteria

Inclusion Criteria

  • parturient aged\>18 years old

Exclusion Criteria

  • Patients who refused to participate in the study
  • History of a disorder associated with pruritus
  • Patients having fentanyl allergy
  • Patients with known allergy to ondansetron
  • Patients who have existing itching with unknown cause
  • Patients who took IV opioid and ondansetron preoperatively
  • Patients having preexisting pregnancy induced pruritus
  • Patients with complicated pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials